GOSS – gossamer bio, inc. (US:NASDAQ)
Stock Stats
News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
Gossamer Bio (GOSS) had its price target lowered by Oppenheimer Holdings, Inc. from $12.00 to $3.00. They now have an "outperform" rating on the stock.
GOSS: Management Optimistic About Topline Results -- LEVI & KORSINSKY, LLP Investigates After Trial Fails
GOSS: Announces Topline Results for Phase 3 PROSERA Trial -- LEVI & KORSINSKY, LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
Form SCHEDULE 13G Gossamer Bio, Inc. Filed by: 683 Capital Management, LLC
Form SCHEDULE 13D/A Gossamer Bio, Inc. Filed by: Growth Equity Opportunities 18 VGE, LLC
Form SCHEDULE 13G/A Gossamer Bio, Inc. Filed by: Octagon Capital Advisors LP
Form S-3ASR Gossamer Bio, Inc.
Form SCHEDULE 13G/A Gossamer Bio, Inc. Filed by: BlackRock, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.